Statements (56)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Insurance_Company
|
gptkbp:annualVisitors |
Yes
Once a Year |
gptkbp:claims |
Market Research
Financial Assessment Legal Review Comprehensive Analysis |
gptkbp:currency |
Euro
|
gptkbp:establishedIn |
2000
|
gptkbp:fledgingPeriod |
Company Performance
Market Conditions Secondary Sale Buyback Strategic Opportunities Initial_Public_Offering |
gptkbp:focusesOn |
Private_Equity_Investments
|
gptkbp:funding |
Closed-End Fund
500 million Euros Divestment Phase Fundraising Phase Investment Phase |
gptkbp:geographicalFeature |
gptkb:Nordic_Region
|
gptkbp:hasFunding |
100,000 Euros
|
gptkbp:hasMember |
Annual
Quarterly |
gptkbp:headquarteredIn |
gptkb:Copenhagen
|
https://www.w3.org/2000/01/rdf-schema#label |
Nordea Private Equity Fund
|
gptkbp:impact |
Yes
|
gptkbp:investmentFocus |
Healthcare
High Net Worth Individuals Institutional Investors Technology Yes Consumer Goods Regular Updates 5-10 years Transparent Communication Market Potential Scalable Business Model Dedicated Team Diversified_Portfolio Venture_Capital Strong_Management_Team Financial_Services |
gptkbp:managedBy |
gptkb:Nordea_Investment_Management
|
gptkbp:partnerships |
gptkb:Nordea_Group
Various_Venture_Capital_Firms |
gptkbp:patentFamilyMembers |
Financial Analysts
Experienced Professionals Industry Experts |
gptkbp:performance |
gptkb:MSCI_World_Index
|
gptkbp:regulatoryBody |
gptkb:Financial_Supervisory_Authority_of_Denmark
|
gptkbp:sustainability |
Environmental Responsibility
Governance Standards Social_Responsibility |
gptkbp:targets |
8-10% per annum
|